Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    11001897 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
Condition: Sickle Cell Disease
Intervention: Other: SCD Group
2 Completed
Has Results
Simvastatin (Zocor) Therapy in Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: Simvastatin
3 Completed Nitric Oxide to Improve Blood Flow in Sickle Cell Disease
Condition: Sickle Cell Anemia
Interventions: Drug: L-NMMA;   Drug: Acetylcholine

Indicates status has not been verified in more than two years